[HTML][HTML] The safety and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis (dTpa) booster vaccine in healthy Vietnamese children

DD Anh, G Jayadeva, S Kuriyakose, HH Han - Vaccine, 2016 - Elsevier
Despite effective infant immunization against pertussis, the disease continues to circulate
due to waning immunity. Booster vaccinations against pertussis beyond infancy are widely …

The safety and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis (dTpa) booster vaccine in healthy Vietnamese children.

DDA Dang Duc Anh, GJ Girish Jayadeva… - 2016 - cabidigitallibrary.org
Despite effective infant immunization against pertussis, the disease continues to circulate
due to waning immunity. Booster vaccinations against pertussis beyond infancy are widely …

Reactogenicity and immunogenicity of reduced antigen content diphtheria–tetanus–acellular pertussis vaccine (dTpa) administered as a booster to 4–6 year-old …

P Kosuwon, B Warachit, Y Hutagalung, T Borkird… - Vaccine, 2003 - Elsevier
A trial to compare the reactogenicity and immunogenicity of a reduced antigen content
diphtheria–tetanus–acellular pertussis (dTpa) vaccine with diphtheria–tetanus–whole-cell …

[HTML][HTML] Safety and reactogenicity of a low-dose diphtheria-tetanus-acellular pertussis vaccine (BoostrixTM) in pre-school Indian children

A Bose, AP Dubey, D Gandhi, A Pandit… - Indian …, 2007 - indianpediatrics.net
Objective: To evaluate the safety and reactogenicity of a reduced-antigen-content combined
Diphtheria-Tetanus-Acellular Pertussis (dTpa) vaccine in Indian pre-school children …

Booster vaccination against pertussis in Chinese children at six years of age using reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (Boostrix™ …

F Zhu, S Zhang, Q Hou, Y Zhang, Y Xu, X Ma… - Human …, 2010 - Taylor & Francis
Pertussis continues to circulate in Chinese communities and older children, adolescents and
adults are sources of infection for unprotected infants. Two studies conducted in Jiangsu …

Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine in healthy Taiwanese children and adolescents.

HLM Huang LiMin, CLY Chang LuanYin… - 2005 - cabidigitallibrary.org
Abstract Purpose: Disease caused by Bordetella pertussis is increasingly being identified
among older children and adults in immunized populations, indicating a waning of the …

Reactogenicity and immunogenicity of reduced antigen content diphtheria–tetanus–acellular pertussis vaccines as a booster in 4–7-year-old children primed with …

R Dagan, K Igbaria, L Piglansky, F Van Brusteghem… - Vaccine, 1999 - Elsevier
Background. The recent introduction of acellular pertussis vaccines (Pa) offers the possibility
of booster doses in older children and adults. This can be conveniently accomplished by …

[HTML][HTML] The effectiveness and safety of pertussis booster vaccination for adolescents and adults: A systematic review and meta-analysis

J Xu, S Liu, Q Liu, R Rong, W Tang, Q Wang, S Kuang… - Medicine, 2019 - journals.lww.com
Background: Due to the resurgence of pertussis, many countries have revised the pertussis
immunization schedules and recommended booster doses of pertussis component vaccine …

Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine in healthy Taiwanese children and adolescents

LM Huang, LY Chang, H Tang, HL Bock, CY Lu… - Journal of Adolescent …, 2005 - Elsevier
PURPOSE: Disease caused by Bordetella pertussis is increasingly being identified among
older children and adults in immunized populations, indicating a waning of the vaccine …

Safety of reduced-antigen-content tetanus–diphtheria–acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis–containing vaccine

F Zepp, M Knuf, P Habermehl… - The Journal of …, 2006 - Elsevier
OBJECTIVE: The safety of a booster dose of a reduced-antigen-content tetanus–diphtheria–
acellular pertussis (Tdap) vaccine was evaluated in adolescents previously vaccinated with …